Project Grant R21AI178560
Award Date
7/1/24
Completion Date
5/31/26
Dollars Obligated
$476K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Boston, MA 02118, USA
Similar Awards
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $242,310 to establish a human intestinal organoid model to study the pathophysiological effects of filovirus (e.g., Ebola, Marburg) infection on the intestinal epithelium. The research aims to characterize how filovirus infection compromises intestinal barrier and tight junction integrity, as well as to...
The Project Grant award of $515,282.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to provide a detailed understanding of the molecular mechanisms underlying HIV spread through cell-to-cell contact. The research will leverage a novel flow cytometry assay and APEX proximity labeling technology to identify determinants and composition of the virological synapse, analyze how synapse formation...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $218,900.00 to the University of Alabama at Birmingham to conduct research on elucidating the proteolytic determinants of flavivirus infection. The research aims to advance understanding of the molecular factors influencing flavivirus protease cleavage of intracellular substrates and the impact on viral fitness....
This federal Project Grant award of $15,083,516.00 from the Department of Health and Human Services National Institutes of Health under the Construction Support program (CFDA 93.352) will fund the modernization and renovation of the National Emerging Infectious Diseases Laboratories (NEIDL) at Boston University. The primary goals are to: 1) Modify the Biosafety Level (BSL)-3 and Animal Biosafety Level (ABSL)-3 spaces to allow for individual room isolation and decontamination, 2) Renovate the...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $734,184 to support research on the mechanisms of parainfluenza virus genome replication. The award to Trustees of Boston University Medical Campus will fund a 5-year study to investigate how the viral polymerase complex regulates the balance between viral transcription and replication processes. The research aims to...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $681,755 to the Albert Einstein College of Medicine to delineate the mechanisms of intracellular assembly, maturation, trafficking, and activity of glycoprotein complexes from four rodent-infecting hantaviruses. The research aims to identify and define virus-host interactions required for endoplasmic...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $2,660,212 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Children's Hospital Corporation (doing business as Boston Children's Hospital) for the project "Armed Nanobodies as Anti-Infectives and Anti-Tumor Agents". The goal is to develop a therapeutic approach using nanobodies (small antibody fragments) that recognize immunoglobulin light chains, which can be...
This $502,043 project grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will fund research on how transition metals shape the function of two important enzyme superfamilies: viral proteases and SAMHD1 dNTPases. The award, which runs from May 1, 2025 to February 28, 2030, aims to bridge the gap in understanding how metal ions affect the activity and regulation of these enzymes that are critical at the...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $824,331 to support research on understanding the formation and dynamics of the SIV (simian immunodeficiency virus) reservoir. The research aims to explore the role of naive CD4+ T cells in establishing and maintaining the intact viral reservoir, particularly in the context of early antiretroviral therapy (ART)...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to develop a proteomics atlas of HIV/HBV co-infections to support the discovery and validation of host factors and antivirals for a functional cure for hepatitis B virus (HBV). The $673,158 award to Emory University, with sub-awards to the University of Zurich and Weill Medical College of Cornell University, will...